Buhnerkempe MG - Search Results

1

Predicting the risk of apparent treatment-resistant hypertension: a longitudinal, cohort study in an urban hypertension referral clinic.

Buhnerkempe MG, Botchway A, Nolasco Morales CE, Prakash V, Hedquist L, Flack JM. Buhnerkempe MG, et al. J Am Soc Hypertens. 2018 Nov;12(11):809-817. doi: 10.1016/j.jash.2018.09.006. Epub 2018 Sep 20. J Am Soc Hypertens. 2018. PMID: 30392848

2

Prevalence of refractory hypertension in the United States from 1999 to 2014.

Buhnerkempe MG, Botchway A, Prakash V, Al-Akchar M, Nolasco Morales CE, Calhoun DA, Flack JM. Buhnerkempe MG, et al. J Hypertens. 2019 Sep;37(9):1797-1804. doi: 10.1097/HJH.0000000000002103. J Hypertens. 2019. PMID: 31058798

3

Serious Adverse Events Cluster in Participants Experiencing the Primary Composite Cardiovascular Endpoint: A Post Hoc Analysis of the SPRINT Trial.

Botchway A, Buhnerkempe MG, Prakash V, Al-Akchar M, Adekola B, Flack JM. Botchway A, et al. Among authors: buhnerkempe mg. Am J Hypertens. 2020 May 21;33(6):528-533. doi: 10.1093/ajh/hpaa010. Am J Hypertens. 2020. PMID: 31930338

4

Adverse Health Outcomes Associated With Refractory and Treatment-Resistant Hypertension in the Chronic Renal Insufficiency Cohort.

Buhnerkempe MG, Prakash V, Botchway A, Adekola B, Cohen JB, Rahman M, Weir MR, Ricardo AC, Flack JM. Buhnerkempe MG, et al. Hypertension. 2021 Jan;77(1):72-81. doi: 10.1161/HYPERTENSIONAHA.120.15064. Epub 2020 Nov 9. Hypertension. 2021. PMID: 33161774 Free PMC article.

5

Race and Antihypertensive Drug Therapy: Edging Closer to a New Paradigm.

Flack JM, Buhnerkempe MG. Flack JM, et al. Among authors: buhnerkempe mg. Hypertension. 2022 Feb;79(2):349-351. doi: 10.1161/HYPERTENSIONAHA.121.18545. Epub 2022 Jan 12. Hypertension. 2022. PMID: 35020461 Free article. No abstract available.

6

Resistant Hypertension: Disease Burden and Emerging Treatment Options.

Flack JM, Buhnerkempe MG, Moore KT. Flack JM, et al. Among authors: buhnerkempe mg. Curr Hypertens Rep. 2024 May;26(5):183-199. doi: 10.1007/s11906-023-01282-0. Epub 2024 Feb 16. Curr Hypertens Rep. 2024. PMID: 38363454 Free PMC article. Review.

7

Sacubitril/Valsartan as an Effective Hypertension Treatment Option in Those With Chronic Type B Aortic Dissection.

Buhnerkempe MG, Bitner S, Flack JM. Buhnerkempe MG, et al. Am J Hypertens. 2024 Jul 15;37(8):543-545. doi: 10.1093/ajh/hpae054. Am J Hypertens. 2024. PMID: 38708518 No abstract available.

8

Risk Factors for Infection After Minor Dermatologic Procedures: A Case-Control Study.

Matos S, Sturm B, Buhnerkempe M, Larson R, Wilson M. Matos S, et al. Dermatol Surg. 2021 Dec 1;47(12):1562-1565. doi: 10.1097/DSS.0000000000003163. Dermatol Surg. 2021. PMID: 34417389

9

The staining of clothing by sunscreens: A pilot study.

Ginnetti M, Buhnerkempe M, Wilson M. Ginnetti M, et al. J Am Acad Dermatol. 2018 Sep;79(3):562-564. doi: 10.1016/j.jaad.2018.02.022. Epub 2018 Feb 10. J Am Acad Dermatol. 2018. PMID: 29438759 No abstract available.

10

Initiation of methotrexate with or without a test dose: A retrospective toxicity study.

Herrmann T, Buhnerkempe M, Wilson ML. Herrmann T, et al. J Am Acad Dermatol. 2019 Apr;80(4):1160-1162. doi: 10.1016/j.jaad.2018.12.015. Epub 2018 Dec 15. J Am Acad Dermatol. 2019. PMID: 30562566 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters